Obagi Medical Products Makes Donation to New Orleans City Park

Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, has made a donation to the New Orleans City Park in conjunction with the American Academy of Dermatology meeting being held in New Orleans.

"We are proud to support the rebuilding efforts of the City of New Orleans, and specifically, an organization that provides benefit to so many people in the community,” said Jim Hartman, Vice President of Global Marketing and Business Development at Obagi Medical. "In addition to being a leader in professional skin care, we aim to contribute to the communities we visit to help improve lives. It’s a philosophy we call Changing Skin, Changing Lives.”

A popular place to picnic, partake in a wide variety of sports, wander through gardens or take a boat ride, City Park hosts 11 million visitors each year. Centrally located in the city, it has a special place in the hearts of generations of New Orleanians and is a must visit for visitors to the city. The park’s 1,300 acres of parkland provide enjoyment for everyone from young children playing on its playgrounds to walkers, joggers, and bicyclists winding through the park's streets and trails.

"New Orleans City Park is a beautiful and historical part of New Orleans,” said Dr. Mary Lupo, Board Certified Dermatologist, nationally recognized educator in the field of cosmetic dermatology and owner of Lupo Center for Aesthetic and General Dermatology. "As a resident of New Orleans and avid supporter of the City Park, we are very appreciative of Obagi’s support.”

Despite occupying land owned by the City of New Orleans, City Park only receives public monetary support equivalent to about 19 percent of their total costs of operation. Obagi Medical Products is proud to donate to sustaining such a substantial part of life in New Orleans, which greatly enriches the lives of all of its residents.

About Obagi Medical Products, Inc.

Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, and is a leading provider of, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeutics™ technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly stable vitamin C serums), Obagi Condition &Enhance® for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm® Eye Treatment and Obagi CLENZIderm® M.D. acne therapeutic systems, a formulation of Obagi CLENZIdermM.D. Systems for normal to dry skin, and Obagi ELASTIderm Décolletage System, Obagi Rosaclear®System, Obagi ELASTILash™ Eyelash Solution, Obagi Blue Peel RADIANCE^TM, and Nu-Derm® Sun Shield SPF 50. Visit www.obagi.com for information.